Advertisement

Methods for the Investigation of Thyroid Function

  • Alireza Morovat
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1065)

Abstract

In the developed world, all routine clinical laboratories should be able to perform tests for the assessment of the pituitary–thyroid axis. Testing strategies usually involve the measurement of thyroid-stimulating hormone (TSH), either alone or in combination with free thyroxine (FT4), which itself should also be measured when TSH is abnormal or if there is a suspicion of pituitary disease. Based on these findings, clinical history and medications such as amiodarone, free tri-iodothyronine (FT3), thyroid-binding globulin (TBG), and/or autoantibodies may then be measured.

All these assays have their individual challenges. For example, sensitivity of a TSH assay is of crucial importance for improving distinction between eu- and hyperthyroidism. In the measurement of free hormones, there is the potential disturbance of the equilibrium between free and bound moieties by separating systems. There are a number of commercial diagnostic kits available for each of these tests. This chapter presents various representative assays and their principles. With the exception of FT4 determination by equilibrium dialysis, those that employ a 96-well plate format and use non-isotopic techniques have been described. Attention has been paid to limitations of the assays, standardization of assay kits, imprecision, recovery, detection limit, and ease of use. The assays described have been given as typical and reliable examples, but it is the responsibility of assayists to choose methods that are best suited to their needs.

Key words

Thyroid-stimulating hormone TSH Free thyroxine FT4 Free tri-iodothyronine FT3 Thyroxine T4 Tri-iodothyronine T3 Thyroid-binding globulin TBG Thyroid antibodies Equilibrium dialysis Immunoassay, Immunometric assay 

References

  1. 1.
    Association of Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation (2006) UK guidelines for the use of thyroid function tests. http://acb.org.uk/docs/tftguidelinefinal.pdf (Accessed July 2013)
  2. 2.
    Stockigt J (2003) Assessment of thyroid function: towards an integrated laboratory—clinical approach. Clin Biochem Rev 24:109–122PubMedGoogle Scholar
  3. 3.
    Beckett G, Toft T, O’Kane M (2007) Thyroid function tests in the UK. www.acb.org.uk/docs/TFTprofile.pdf (Accessed July 2013)
  4. 4.
    Snyder PJ, Utiger RD (1972) Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest 51:2077–2084PubMedCrossRefGoogle Scholar
  5. 5.
    Vagenakis AG, Rapoport B, Azizi F et al (1974) Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 54:913–918PubMedCrossRefGoogle Scholar
  6. 6.
    Spencer CA, Takeuchi M, Kazarosyan ME (1995) Interlaboratory differences in functional sensitivity of immunometric assays of thyrotropin and impact on relaibility of measurement of subnormal concnetrations of TSH. Clin Chem 4:367–374Google Scholar
  7. 7.
    Spencer CA, Takeuchi M, Kazarosyan M (1996) Current status and performance goals for serum TSH assays. Clin Chem 42:140–145PubMedGoogle Scholar
  8. 8.
    Hay ID, Bayer MF, Kaplan MM et al (1991) American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurementsand guidelines for future clinical assays. Clin Chem 37:2002–2008PubMedGoogle Scholar
  9. 9.
    Mendel CM (1989) The free hormone hypothesis: a physiolocally based mathematical model. Endocr Rev 10:232–274PubMedCrossRefGoogle Scholar
  10. 10.
    Mendel CM (1992) The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl 13:107–116PubMedGoogle Scholar
  11. 11.
    Ekins R (1990) Measurements of free hormones in blood. Endocr Rev 11:5–46PubMedCrossRefGoogle Scholar
  12. 12.
    Ekins R (1992) The free hormone hypothesis and measurement of free hormones. Clin Chem 38:1289–1293PubMedGoogle Scholar
  13. 13.
    Yue B, Rockwood AL, Sandrock T et al (2008) Free thyroid hormones in serum by direct equilibrium dialysis and online solid-pahse extraction-liquid chromatography/tandem mass spectrometry. Clin Chem 54:642–651PubMedCrossRefGoogle Scholar
  14. 14.
    Csako G, Zweig MH, Glickman J et al (1989) Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. I. Effect of free fatty acids. Clin Chem 35:102–109PubMedGoogle Scholar
  15. 15.
    Nelson JC, Weiss RM (1985) The effects of serum dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 61:239–246PubMedCrossRefGoogle Scholar
  16. 16.
    Holm SS, Andreasen L, Hansen SH et al (2002) Influence of adsorption and deproteination on potential free thyroxine reference methods. Clin Chem 48:108–114PubMedGoogle Scholar
  17. 17.
    Tikanoja SH (1990) Ultrafiltration devices tested for use in a free thyroxine assay validated by comparison with equilibrium dialysis. Scand J Clin Lab Invest 50:663–669PubMedCrossRefGoogle Scholar
  18. 18.
    Romelli PB, Penrisi F, Vancheri L (1979) Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay. J Endocrinol Invest 2:25–40PubMedGoogle Scholar
  19. 19.
    Jonklaas J, Kahric-Janicic N, Soldin OP et al (2009) Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin Chem 55:1380–1388PubMedCrossRefGoogle Scholar
  20. 20.
    Gu J, Soldin OP, Soldin SJ (2007) Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem 40:1386–1391PubMedCrossRefGoogle Scholar
  21. 21.
    Christofides ND, Midgley JE (2009) Inaccuracies in free thyroid hormone measurement by ultrafiltration and tandem mass spectrometry. Clin Chem 55:2228–2229PubMedCrossRefGoogle Scholar
  22. 22.
    Ross HA, Bernardm TJ (1992) Is free thyroxine accurately measurabe at room temperature? Clin Chem 38:880–887PubMedGoogle Scholar
  23. 23.
    van der Sluijs Veer G, Vermes I, Bonte HA et al (1992) Temperature effects on free thyroxine measurements: analytical and clinical consequences. Clin Chem 38:1327–1331PubMedGoogle Scholar
  24. 24.
    Csako G, Zwieg MH, Glickman J et al (1989) Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness. II. Effect of prealbumin, albumin and thyroxin-binding globulin. Clin Chem 35:1655–1662PubMedGoogle Scholar
  25. 25.
    Stockigt JR, Lim CF (2009) Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab 23:753–767PubMedCrossRefGoogle Scholar
  26. 26.
    Midgley JEM (2001) Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem 47:1353–1363PubMedGoogle Scholar
  27. 27.
    Burr WA, Evans SE, Lee J et al (1979) The ratio of thyroxine to thyroxine-binding globulin measurement in the evaluation of thyroid function. Clin Endocrinol 11:333–342CrossRefGoogle Scholar
  28. 28.
    Attwood EC, Atkin GE (1982) The T4: TBG ratio: a re-evaluation with particular reference to low and high serum TBG levels. Ann Clin Biochem 19:101–103PubMedGoogle Scholar
  29. 29.
    Szpunar WE, Stoffer SS, DiGiulio W (1987) Clinical evaluation of a thyroxine binding globulin assay in calculationg a free thyroxine index in normal, thyroid disease and sick euthyroid patients. J Nucl Med 28:1341–1343PubMedGoogle Scholar
  30. 30.
    Nelson JC, Tomei RT (1989) Dependence of the thyroxin/thyroxin-binding globulin (TBG) ratio and the free thyroxin index on TBG concentrations. Clin Chem 35:541–544PubMedGoogle Scholar
  31. 31.
    Wilcox RB, Nelson JC, Tomei RT (1994) Heterogeneity in affinities of serum proteins for thyroxine among patients with non-thyroidal illness as indicated by the serum free thyroxine response to serum dilution. Eur J Endocrinol 131:9–13PubMedCrossRefGoogle Scholar
  32. 32.
    Evans SE, Burr WA, Hogan TC (1977) A reassessment of 8-anilino-1-naphthalene sulphonic acid as a thyroxine binding inhibitor in the radioimmunoassay of thyroxine. Ann Clin Biochem 14:330–334PubMedGoogle Scholar
  33. 33.
    Mariotti S, Caturegli P, Piccolo P et al (1990) Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 71:661–669PubMedCrossRefGoogle Scholar
  34. 34.
    Feldt-Rasmussen U, Hoier-Madsen M, Bech K et al (1991) Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity 9:245–253PubMedCrossRefGoogle Scholar
  35. 35.
    Gilmour J, Brownlee Y, Foster P et al (1991) The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto’s disease, Graves’ disease and a follow-up study on postpartum thyroid disease. Clin Lab 46:57–61Google Scholar
  36. 36.
    Finke R, Bogner U, Kotulla P et al (1994) Anti-TPO antibody determinations using different methods. Exp Clin Endocrinol 102:145–150Google Scholar
  37. 37.
    Feldt-Rasmussen U (1996) Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem 42:160–163PubMedGoogle Scholar
  38. 38.
    Smith BR, Sanders J, Furmaniak J (2007) TSH receptor antibodies. Thyroid 17:923–938PubMedCrossRefGoogle Scholar
  39. 39.
    Ando T, Latif R, Davies TF (2005) Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 19:33–52PubMedCrossRefGoogle Scholar
  40. 40.
    Mizutori Y, Chen CR, Latrofa F et al (2009) Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves’ disease. J Clin Endocrinol Metab 94:927–935PubMedCrossRefGoogle Scholar
  41. 41.
    Ajjan RA, Weetman AP (2008) Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 4:461–468PubMedCrossRefGoogle Scholar
  42. 42.
    Sinclair D (2008) Analytical aspects of thyroid antibodies estimation. Autoimmunity 41:46–54PubMedCrossRefGoogle Scholar
  43. 43.
    Smith BR, Bolton J, Young S et al (2004) A new assay for thyrotropin receptor antibodies. Thyroid 14:830–835PubMedCrossRefGoogle Scholar
  44. 44.
    Kamijo K, Ishilawa K, Tanaka M (2005) Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 52:525–529PubMedCrossRefGoogle Scholar
  45. 45.
    Zöphel K, Roggenbuck D, von Landenberg P et al (2010) TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Horm Metab Res 42:65–69PubMedCrossRefGoogle Scholar
  46. 46.
    Theodoraki A, Jones G, Parker J et al (2011) Performance of a third generation TSH-receptor antibody (TRAb) in a UK clinic. Clin Endo-crinol 75:127–133CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Alireza Morovat
    • 1
  1. 1.Department of Clinical BiochemistryOxford University HospitalsOxfordUK

Personalised recommendations